228 related articles for article (PubMed ID: 19652946)
1. Regulation of skeletal muscle sucrose, non-fermenting 1/AMP-activated protein kinase-related kinase (SNARK) by metabolic stress and diabetes.
Rune A; Osler ME; Fritz T; Zierath JR
Diabetologia; 2009 Oct; 52(10):2182-9. PubMed ID: 19652946
[TBL] [Abstract][Full Text] [Related]
2. siRNA-mediated reduction of inhibitor of nuclear factor-kappaB kinase prevents tumor necrosis factor-alpha-induced insulin resistance in human skeletal muscle.
Austin RL; Rune A; Bouzakri K; Zierath JR; Krook A
Diabetes; 2008 Aug; 57(8):2066-73. PubMed ID: 18443205
[TBL] [Abstract][Full Text] [Related]
3. Signaling specificity of interleukin-6 action on glucose and lipid metabolism in skeletal muscle.
Al-Khalili L; Bouzakri K; Glund S; Lönnqvist F; Koistinen HA; Krook A
Mol Endocrinol; 2006 Dec; 20(12):3364-75. PubMed ID: 16945991
[TBL] [Abstract][Full Text] [Related]
4. Increased pyruvate dehydrogenase kinase expression in cultured myotubes from obese and diabetic individuals.
McAinch AJ; Cornall LM; Watts R; Hryciw DH; O'Brien PE; Cameron-Smith D
Eur J Nutr; 2015 Oct; 54(7):1033-43. PubMed ID: 25311062
[TBL] [Abstract][Full Text] [Related]
5. Cross-talk mechanisms in the development of insulin resistance of skeletal muscle cells palmitate rather than tumour necrosis factor inhibits insulin-dependent protein kinase B (PKB)/Akt stimulation and glucose uptake.
Storz P; Döppler H; Wernig A; Pfizenmaier K; Müller G
Eur J Biochem; 1999 Nov; 266(1):17-25. PubMed ID: 10542046
[TBL] [Abstract][Full Text] [Related]
6. Serine/threonine protein kinase 25 (STK25): a novel negative regulator of lipid and glucose metabolism in rodent and human skeletal muscle.
Nerstedt A; Cansby E; Andersson CX; Laakso M; Stančáková A; Blüher M; Smith U; Mahlapuu M
Diabetologia; 2012 Jun; 55(6):1797-807. PubMed ID: 22391949
[TBL] [Abstract][Full Text] [Related]
7. Differential utilization of saturated palmitate and unsaturated oleate: evidence from cultured myotubes.
Gaster M; Rustan AC; Beck-Nielsen H
Diabetes; 2005 Mar; 54(3):648-56. PubMed ID: 15734839
[TBL] [Abstract][Full Text] [Related]
8. MAP4K4 gene silencing in human skeletal muscle prevents tumor necrosis factor-alpha-induced insulin resistance.
Bouzakri K; Zierath JR
J Biol Chem; 2007 Mar; 282(11):7783-9. PubMed ID: 17227768
[TBL] [Abstract][Full Text] [Related]
9. Evidence against a sexual dimorphism in glucose and fatty acid metabolism in skeletal muscle cultures from age-matched men and post-menopausal women.
Rune A; Salehzadeh F; Szekeres F; Kühn I; Osler ME; Al-Khalili L
Acta Physiol (Oxf); 2009 Nov; 197(3):207-15. PubMed ID: 19508405
[TBL] [Abstract][Full Text] [Related]
10. Reduced insulin-mediated citrate synthase activity in cultured skeletal muscle cells from patients with type 2 diabetes: evidence for an intrinsic oxidative enzyme defect.
Ortenblad N; Mogensen M; Petersen I; Højlund K; Levin K; Sahlin K; Beck-Nielsen H; Gaster M
Biochim Biophys Acta; 2005 Jun; 1741(1-2):206-14. PubMed ID: 15894466
[TBL] [Abstract][Full Text] [Related]
11. Eicosapentaenoic acid (20:5 n-3) increases fatty acid and glucose uptake in cultured human skeletal muscle cells.
Aas V; Rokling-Andersen MH; Kase ET; Thoresen GH; Rustan AC
J Lipid Res; 2006 Feb; 47(2):366-74. PubMed ID: 16301737
[TBL] [Abstract][Full Text] [Related]
12. Altered response of skeletal muscle to IL-6 in type 2 diabetic patients.
Jiang LQ; Duque-Guimaraes DE; Machado UF; Zierath JR; Krook A
Diabetes; 2013 Feb; 62(2):355-61. PubMed ID: 23086036
[TBL] [Abstract][Full Text] [Related]
13. Sestrin 3 regulation in type 2 diabetic patients and its influence on metabolism and differentiation in skeletal muscle.
Nascimento EB; Osler ME; Zierath JR
Am J Physiol Endocrinol Metab; 2013 Dec; 305(11):E1408-14. PubMed ID: 24129397
[TBL] [Abstract][Full Text] [Related]
14. Suppressor of cytokine signaling 3 expression and insulin resistance in skeletal muscle of obese and type 2 diabetic patients.
Rieusset J; Bouzakri K; Chevillotte E; Ricard N; Jacquet D; Bastard JP; Laville M; Vidal H
Diabetes; 2004 Sep; 53(9):2232-41. PubMed ID: 15331532
[TBL] [Abstract][Full Text] [Related]
15. Prolonged exposure to palmitate impairs fatty acid oxidation despite activation of AMP-activated protein kinase in skeletal muscle cells.
Pimenta AS; Gaidhu MP; Habib S; So M; Fediuc S; Mirpourian M; Musheev M; Curi R; Ceddia RB
J Cell Physiol; 2008 Nov; 217(2):478-85. PubMed ID: 18561258
[TBL] [Abstract][Full Text] [Related]
16. Tumor Necrosis Factor-α Promotes Phosphoinositide 3-Kinase Enhancer A and AMP-Activated Protein Kinase Interaction to Suppress Lipid Oxidation in Skeletal Muscle.
Tse MCL; Herlea-Pana O; Brobst D; Yang X; Wood J; Hu X; Liu Z; Lee CW; Zaw AM; Chow BKC; Ye K; Chan CB
Diabetes; 2017 Jul; 66(7):1858-1870. PubMed ID: 28404596
[TBL] [Abstract][Full Text] [Related]
17. The MicroRNA miR-696 is regulated by SNARK and reduces mitochondrial activity in mouse skeletal muscle through Pgc1α inhibition.
Queiroz AL; Lessard SJ; Ouchida AT; Araujo HN; Gonçalves DA; Simões Fróes Guimarães DSP; Teodoro BG; So K; Espreafico EM; Hirshman MF; Alberici LC; Kettelhut IDC; Goodyear LJ; Silveira LR
Mol Metab; 2021 Sep; 51():101226. PubMed ID: 33812060
[TBL] [Abstract][Full Text] [Related]
18. Suppression of Rho-kinase 1 is responsible for insulin regulation of the AMPK/SREBP-1c pathway in skeletal muscle cells exposed to palmitate.
Tang S; Wu W; Tang W; Ge Z; Wang H; Hong T; Zhu D; Bi Y
Acta Diabetol; 2017 Jul; 54(7):635-644. PubMed ID: 28265821
[TBL] [Abstract][Full Text] [Related]
19. Abnormal metabolism flexibility in response to high palmitate concentrations in myotubes derived from obese type 2 diabetic patients.
Kitzmann M; Lantier L; Hébrard S; Mercier J; Foretz M; Aguer C
Biochim Biophys Acta; 2011 Apr; 1812(4):423-30. PubMed ID: 21172433
[TBL] [Abstract][Full Text] [Related]
20. Impaired regulation of the TNF-alpha converting enzyme/tissue inhibitor of metalloproteinase 3 proteolytic system in skeletal muscle of obese type 2 diabetic patients: a new mechanism of insulin resistance in humans.
Monroy A; Kamath S; Chavez AO; Centonze VE; Veerasamy M; Barrentine A; Wewer JJ; Coletta DK; Jenkinson C; Jhingan RM; Smokler D; Reyna S; Musi N; Khokka R; Federici M; Tripathy D; DeFronzo RA; Folli F
Diabetologia; 2009 Oct; 52(10):2169-81. PubMed ID: 19633828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
